An Official Website of the United States Government
Company Information:
Name:
AKTIV-DRY, LLC
Address:
2100 Central Avenue
BOULDER, CO 80301-
BOULDER, CO 80301-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
A New Process for Producing Phytosterol and Lycopene Nano- and Micro-Particles
Award Year / Program / Phase:
2004 / SBIR / Phase I
Agency:
USDA
Principal Investigator:
Brian Quinn
Award Amount:
$79,985.00
Abstract:
Phytosterols and lycopene are neutraceuticals that are known antioxidants and cancer inhibitors. Unfortunately, they do not dissolve readily in body fluids and therefore present unique problems concerning their uptake by the blood stream. This project explores the ability to enhance the rate of… More
Inhalable IgG Synthesis For Influenza Immunoprophylaxis
Award Year / Program / Phase:
2004 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Stephen P. Cape
Award Amount:
$99,600.00
Abstract:
DESCRIPTION (provided by applicant): This Phase I SBIR proposal is the first step in the development of inhalable IgG microparticles for immunoprophylaxis against Influenza A, a category C Priority Pathogen. In Phase I, Aktiv-Dry will simultaneously stabilize, dry, and micronize IgG antibody… More
Product Formulation and Process Design for Commercial Production of Soluable Phytosterols
Award Year / Program / Phase:
2006 / SBIR / Phase II
Agency:
USDA
Principal Investigator:
Brian Quinn
Award Amount:
$296,000.00
Abstract:
Commercially available products rich in phytosterol may now be used to cut serum low-density lipoprotein by as much as 14 percent. Unfortunately, phytosterols are poorly soluble and therefore present unique problems concerning their ability to suppress cholesterol absorption in the gut. This… More
Development of a Micronized Needle-Free Nicotine Vaccine for Smoking Cessation an
Award Year / Program / Phase:
2006 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
James A. Searles
Award Amount:
$99,989.00
Abstract:
DESCRIPTION (provided by applicant): Aktiv-Dry LLC, in collaboration with Nabi Biopharmaceuticals, proposes to develop and evaluate in animal models the needle-free respiratory delivery of fine dry powder nicotine vaccine. While syringe and needle have been a common vaccine administration mechanism,… More
Aktiv-Neb: A Dry Powder Inhaler for Anti-RSV siRNA Microparticles
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$99,990.00
Abstract:
DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to develop a novel dry powder inhalation system, Aktiv-NebTM, for delivering antiviral drug (siRNAs) powders, to the respiratory systems of infants and young
children as an intervention strategy for… More
Development of a Micronized Needle-Free Nicotine Vaccine for Smoking Cessation an
Award Year / Program / Phase:
2008 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Award Amount:
$823,623.00
Abstract:
DESCRIPTION (provided by applicant): Aktiv-Dry LLC, in collaboration with Nabi Biopharmaceuticals, proposes to develop and evaluate in animal models the needle-free respiratory delivery of fine dry powder nicotine vaccine. While syringe and needle have bee
n a common vaccine administration… More
A new, rapidly dissolving and thermally stable dry powder Hepatitis-B vaccine
Award Year / Program / Phase:
2012 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Stephen P. Cape – 303-350-3060
Award Amount:
$939,918.00
Abstract:
DESCRIPTION (provided by applicant): The overarching goal of this project is to move a new, dry powder formulation of Hepatitis-B vaccine on its path to commercialization. In the Phase I SBIR we tested in vitro three Hep-B dry powder formulations of commercially available Shanvac-B and demonstrated… More